美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物科技指数ETF-iShares Nasdaq

189.67

+1.340.71%

成交量：48.51万

成交额：9,197.01万

市值：93.89亿

市盈率：30.05

高：190.93

开：190.03

低：188.82

收：188.33

52周最高：199.05

52周最低：130.25

股本：4,950.00万

流通股本：4,950.00万

量比：0.63

换手率：0.98%

股息：0.41

股息率：0.22%

每股收益(TTM):6.31

每股收益(LYR):-1.4940

净资产收益率：24.54%

总资产收益率：0.10%

市净率：1.15

市盈率(LYR):-126.96

数据加载中...

总览公司新闻公告

解读世界500强榜单医药板块：强生继续“霸榜”，礼来排名上升112位，3家中国企业入选

每日经济新闻

Bitget 已上线 SKDD、GILD、TMF 等 9 只股票永续合约

安进提交新数据，对美国食品药品监督管理局（FDA）关于撤回Tavneos的提议提出异议

吉利德科学(GILD)肿瘤组合疗法获欧洲药品管理局旗下CHMP推荐

CHMP推荐吉利德Trodelvy®联合Keytruda®用于PD-(L)1阳性一线转移性三阴性乳腺癌

百济神州/安进 FIC 双抗，皮下制剂进入 III 期

argenx(ARGX)二季度产品净销售额达15.16亿美元同比增长60%

美国研究综述-Alphabet、IBM、特斯拉

数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法

创新药研发加速遇“猴荒”

吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒

安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解

Leerink Partners下调吉利德科学评级至“与大盘持平”，目标价大幅调降至127美元

Leerink下调吉利德科学目标价至127美元

Kalshi将允许对临床试验和FDA决定进行投注

三星生物制剂与欧加农将在澳大利亚推出新型生物类似药。

刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验

Vertex(VRTX)百亿美元收购罕见病药企拓宽内分泌管线布局

Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事会

RBC将Kymera Therapeutics的评级下调至“与行业持平”，并上调目标价

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IBB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指数ETF-iShares Nasdaq","latestPrice":189.67,"timestamp":1785260478338,"preClose":188.33,"halted":0,"volume":485081,"delay":0,"changeRate":0.007115170180003053,"floatShares":49500000,"shares":49500000,"eps":6.311863,"marketStatus":"交易中","change":1.34,"latestTime":"07-28 13:41:30 EDT","open":190.03,"high":190.93,"low":188.8231,"amount":91970125.49426001,"amplitude":0.011187,"askPrice":189.72,"askSize":74,"bidPrice":189.65,"bidSize":60,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1785268800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":188.33,"sharesOutstanding":49450000,"nav":188.173992,"aum":9352247402.4,"dividendRate":0.002182,"bidAskSpread":0.00038,"preHourTrading":{"tag":"盘前","latestPrice":189.6,"preClose":188.33,"latestTime":"09:27 EDT","volume":898,"amount":170329.52394,"timestamp":1785245220404,"change":1.27,"changeRate":0.006743,"amplitude":0.016036},"postHourTrading":{"tag":"盘后","latestPrice":188.33,"preClose":188.33,"latestTime":"19:51 EDT","volume":12869,"amount":2423625.6721,"timestamp":1785196318395,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.627358,"impliedVol":0.239,"impliedVolPercentile":0.6255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":49500000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.627358,"shares":49500000,"dividePrice":0.4139,"high":190.93,"amplitude":0.011187,"preClose":188.33,"low":188.8231,"week52Low":130.25,"pbRate":"1.15","psRate":"225.88","week52High":199.05,"institutionHeld":0,"latestPrice":189.67,"committee":-0.104478,"eps":6.311863,"divideRate":0.002182,"volume":485081,"delay":0,"ttmEps":6.311863,"open":190.03,"prevYearClose":168.77,"prevWeekClose":188.14,"prevMonthClose":190.19,"prevQuarterClose":190.19,"fiveDayClose":189.31,"twentyDayClose":189.79,"sixtyDayClose":168.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654007935","title":"解读世界500强榜单医药板块：强生继续“霸榜”，礼来排名上升112位，3家中国企业入选","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007935","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007935?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 20:51","pubTimestamp":1785243108,"startTime":"0","endTime":"0","summary":"7月28日，2026年《财富》世界500强榜单正式发布。《每日经济新闻》记者注意到，医疗健康板块作为全球五大支柱行业之一，共有31家企业上榜。其中，礼来公司排名从2025年的336位上升至今年的224位，成为今年上涨最快的10家公司之一。中国公司中，中国医药集团、上海医药、广药集团3家公司再次入围。《每日经济新闻》记者注意到，位居医疗健康相关企业榜首的是联合健康集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823749452.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823749452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","SG9999014906.USD","LU1267930730.SGD","LU1066053197.SGD","LU0011850046.USD","IE00B2B36J28.USD","LU2242646821.SGD","IE00B3T34201.USD","LU1894683264.USD","LU2324357040.USD","IE000SO60NU8.SGD","LU0203347892.USD","LU0162691827.USD","UNHG","CANC","LU2471134523.USD","PAWZ","IE00BFSS8Q28.SGD","LU0545039389.USD","RHHBY","LU0889566641.SGD","IE00BVYPNW00.USD","LU0471298777.SGD","LU1037948541.HKD","LU1670628061.USD","ELIS","IE00BJJMRZ35.SGD","LU1983299246.USD","PBE","IE00BWXC8680.SGD","LU1718418525.SGD","LU2491049909.HKD","LU0342679015.USD","BK4154","LU0726765562.USD","LU1267930227.SGD","LU0187121727.USD","LU0109391861.USD","LU0354030438.USD","LU2106854487.HKD","LU2491050071.SGD","LU1974910355.USD","LU0094547139.USD","IE00B19Z8X17.USD","IE00BBT3K403.USD","LU2347655156.SGD","LU2168563687.JPY","MEDI","LU0965509010.AUD","IE00BDGV0183.EUR","OZEM","SG9999003800.SGD","IYH","LU2596442595.SGD","LU1629891620.HKD","PJP","LU1914381329.SGD","LU0256863811.USD","LU1267930490.SGD","LU2168564495.EUR","LU1935042991.SGD","LU2746668461.USD","LU0306807586.USD","SG9999002232.USD","LU1162221912.USD","LU1228905540.USD","LU1043141123.HKD","LU0203202063.USD","LU2028103732.USD","LU1814569148.SGD","LU0251132253.USD","LU0868494617.USD","LU1201861249.SGD","LU2279689827.SGD","SG9999015986.USD","GDOC","LU2125909247.SGD","LU0320765646.SGD","LU2087625088.SGD","LU0683600562.USD","LU1989772923.USD","LU1934455194.USD","04332","LU0823434583.USD","RXL","IE00B7SZLL34.SGD","LU0208291251.USD","LU2347655073.USD","LU2896262040.SGD","IE00B19Z9505.USD","LU1084165304.USD","SG9999015341.SGD","IE0000B7K699.USD","LU0689626769.HKD","LU0265550359.USD","LU0672654240.SGD","IE00BN8TJ469.HKD","LU0354030511.USD","LU0006306889.USD","BK4566","SG9999014914.USD","LU1043141396.HKD","LU2602419157.SGD","LU0985481810.HKD","LU2403377893.USD","SG9999001176.USD","LU0795875086.SGD","IE00B7KXQ091.USD","LU0861579265.USD","LU0128525929.USD","LU0265550946.USD","IHE","LU2357627491.SGD","SG9999002224.SGD","LU2271345857.HKD","LU1941712348.USD","LU2265009873.SGD","LU0823434740.USD","LU2471134952.CNY","LU0097036916.USD","LU1778281490.HKD","IE000WAW04H5.SGD","TBXU","LU0553294199.USD","LU0787776722.HKD","LU0053666078.USD","LU2168564065.EUR","LU2361045086.USD","LU0225284248.USD","LU0661504455.SGD","LU1623119135.USD","LU1093756325.SGD","LU0130517989.USD","BK4559","BK4504","LU0143551892.USD","LU2362541513.USD","LU1291159041.SGD","LU1127390331.HKD","LU1244550577.SGD","LU0234572021.USD","LLYZ","LU0289961442.SGD","LU0417517546.SGD","BK4534","LU0395794307.EUR","LU2244417387.USD","TMED","LU2125154935.USD","LU1267930813.SGD","LU1934455277.USD","LU1506573853.SGD","TRUH","LU2237443465.HKD","LU2125909593.SGD","SG9999014559.SGD","BK4139","LU0052756011.USD","IE0002270589.USD","LU0432979614.USD","LU0289739343.SGD","SG9999015952.SGD","IE00BZ9MQY76.HKD","LU1791710400.SGD","LU1069347547.HKD","SG9999011175.SGD","LU1989772840.SGD","LU0353189680.USD","LU0820561909.HKD","IE00BLSP4239.USD","UNHW","AMGN","LU0072461881.USD","LU0912757837.SGD","LU1280957306.USD","LU1868837136.USD","LU2505996681.GBP","MHIP","LU0964807845.USD","LU1988902786.USD","SG9999017495.SGD","LU1732800096.USD","LU1923622614.USD","LU0107464264.USD","LU2168564222.USD","PPH","LU0882574139.USD","LU0170899867.USD","LU0456855351.SGD","SGXZ51526630.SGD","LU2471134796.USD","LU1323610961.USD","LU1232071149.USD","LU0511384066.AUD","IE00BK4W5M84.HKD","LU0795875169.SGD","LU2552382215.SGD","LLYX","IE0009355771.USD","LU0316494557.USD","LU0496365809.HKD","LU0310800965.SGD","LU0124676726.USD","LU1720051108.HKD","LU2023250504.SGD","XLV","LU0256863902.USD","LU0198837287.USD","LU0210528500.USD","LU1496350171.SGD","SG9999013999.USD","LU1548497426.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU2087621335.USD","LU0823416689.USD","LU2242652126.USD","LU0211328371.USD","LU1228905037.USD","LU0048584097.USD","IE00B4JS1V06.HKD","LU0792757196.USD","SG9999001440.SGD","SG9999001176.SGD","IE00B1XK9C88.USD","LU2237443978.SGD","LU2236285917.USD","LU2237443895.HKD","LU0471298694.HKD","LU0820561818.USD","LU0321505439.SGD","BBH","LU2456880835.USD","IE00BK4W5L77.USD","LU1037948897.HKD","LU0122379950.USD","LU0128525689.USD","LU2461242641.AUD","UNHU","LU1366192091.USD","LU0203345920.USD","LU0786609619.USD","LU2108987350.USD","LU2362540622.SGD","LU0689472784.USD","GLAM","LU1854103824.USD","IE00BJLML261.HKD","CURE","IE00B4R5TH58.HKD","FTXH","LU1035775433.USD","LU2237443549.SGD","SG9999018857.SGD","IE00B3PB1722.GBP","LU2491050154.USD","LU2023250843.SGD","LU0310799852.SGD","LU0345769631.USD","LU1066051498.USD","SG9999014880.SGD","IE0004445239.USD","LU0472753341.HKD","LU0211326755.USD","LU0096364046.USD","LU0320765992.SGD","ILDR","BK4533","SGXZ31699556.SGD","LU0109394709.USD","LU0426412945.USD","LU1061106388.HKD","LU0321505868.SGD","LU0320765489.SGD","LU2999663052.SGD","LU2362541273.HKD","VHT","BK4532","LU0306806265.USD","LU1003077747.HKD","LU2237443622.USD","IE000MB6IJN5.SGD","LU2242649171.HKD","LU1868836591.USD","SG9999014567.USD","IE00BSNM7G36.USD","LU1244550494.USD","LU0234570918.USD","LU0266013472.USD","LU0070302665.USD","LU0114720955.EUR","LU2552382132.HKD","LU1917777945.USD","LU2430703095.HKD","SG9999015945.SGD","LU2237438978.USD","IE00B775H168.HKD","LU1883839398.USD","LU0385154629.USD","BK4007","LU1196500208.SGD","SG9999018865.SGD","LU2750360997.AUD","LU1674673428.USD","LU2129689514.USD","LU0106261372.USD","LU0130102774.USD","LU2211815571.USD","LU2213496289.HKD","LU1674673691.USD","LU2360032135.SGD","BIB","LU1868836914.USD","LU1153585028.USD","LU0889565916.HKD","LU0149725797.USD","IE00B894F039.SGD","UNH","LU0158827781.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0640476718.USD","LU1093756168.USD","IE0001KFT4U8.USD","SG9999014542.SGD","LU2063271972.USD","LU1221951046.USD","LU2357305700.SGD","LU0069063385.USD","LU2133065610.SGD","JDOC","LU1934455863.HKD","JNJ","LU0058720904.USD","LU2462591277.SGD","LU0738911758.USD","IE00BLSP4452.SGD","LU1670627923.USD","WDNA","LU0210536198.USD","BMED","LU1116320901.HKD","IE00BVYPNV92.GBP","LU0070217475.USD","LU0154236417.USD","LU1699723380.USD","LU0158827948.USD","BK4578","LU1032955483.USD","NVOX","IXJ","LU1145028129.USD","LU0942090050.USD","IE000M9KFDE8.USD","LU0648001328.SGD","LU0868494708.USD","LU1720051017.SGD","LU2360106947.USD","SG9999014898.SGD","LU1119994496.HKD","LU1430594728.SGD","LU2756315318.SGD","MRK","LU0345769128.USD","LU2433249047.HKD","ELIL","IE00BJJMRY28.SGD","LU2756315664.SGD","LU1074936037.SGD","LU2552382058.USD","LU1069344957.HKD","IE00BKPKM429.USD","IE00BFXG1179.USD","IE00B1BXHZ80.USD","NVOH","LU1868837300.USD","LU2089984988.USD","LU2237443382.USD","LU0211331839.USD","LLII","LU2112291526.USD","LU2125154778.USD","LU2089283258.USD","LU0098860793.USD","IE00BN29S564.USD","LU1868836757.USD","IE0002141913.USD","LU2462157665.USD","LU2954938101.SGD","LU2264538146.SGD","THNR","IE000F7OJYX1.SGD","LLY","MEDX","LU2462591350.SGD","IBBQ","AGNG","LU0426417589.USD","LU0943347566.SGD","IE00B42XCP33.USD","LU2111349929.HKD","LU1571399168.USD","LU2487616109.SGD","SGXZ99366536.SGD","LU1064131342.USD","LU0965509101.SGD","PFE","BK4516","BK4599","LU1057294990.SGD","LU2089284900.SGD","LU0965508806.USD","LU0238689110.USD","LU1035773651.USD","SGXZ57979304.SGD","LU0203201768.USD","LU0994945656.USD","LU0079474960.USD","LU1791710582.SGD","IE00BKVL7J92.USD","LU1929549753.HKD","LU0133085943.USD","LU1023059063.AUD","LU2592432038.USD","LU0057025933.USD","LU1032466523.USD","LU0466842654.USD","BK4588","LU1496350502.SGD","LU0985320562.USD","IE0004445015.USD","LU2129689605.HKD","LU0345770993.USD","LU0859254822.USD","FHLC","IE00B19Z8W00.USD","LU0949170772.SGD","03165","LU1732799900.SGD","LU1941712264.USD","LU0029864427.USD","IBB","LU1839511570.USD","IHF","LU1121112475.USD","LU1059921491.USD","LU0708995401.HKD","HRTS","LU1551013342.USD","LU1712237335.SGD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","LU2471134879.HKD","SG9999015358.SGD","LU1854104046.USD","LU2505996509.AUD","LU0557290698.USD","LU0545562505.USD","BK4550","BK4581","LU0820562030.AUD","IE000BZT7R73.USD","LU1066051811.HKD","LU1989771016.USD","LU0976567544.SGD","LU0320765059.SGD","LU0174119429.USD","NVS","LU1585245621.USD","LU1116320737.USD","ABBV","LU1066051225.USD","LU0211327993.USD","IE0034235303.USD","LU2129689431.USD","LU0353189763.USD","IE00BJJMRX11.SGD","LU0077335932.USD","LU1551013425.SGD","BK4585","LU2361044949.HKD","IE00B19Z9Z06.USD","IE00BKDWB100.SGD","IE0005OL40V9.USD","IE00BFSS7M15.SGD","SG9999015978.USD","LU2430703251.USD","LU1221951129.SGD","LU0225283273.USD","LU0323591593.USD","LU0882574055.USD","LU0965509283.SGD","LU1804176565.USD","LU0980610538.SGD","LU2417539215.USD","NVO","IE00B19Z9P08.USD","LU0310800379.SGD","LU1267930573.SGD","LU2468319806.SGD","IE00BGHQF631.EUR","LU0345770308.USD","BK4592","LU0528227936.USD","LU2023250330.USD","LU0708994859.HKD","LU0477156953.USD","LU2746668974.SGD","LU2168564149.EUR","SG9999014575.USD","IE00B19Z3B42.SGD","LU0211326839.USD","LU2361044865.SGD","SGXZ81514606.USD","LU1244550221.USD","GB00BDT5M118.USD","LU0289739699.SGD","LU2430703178.SGD","LU1894683348.USD","LU2023251221.USD","LU2750360641.GBP","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654027040","title":"Bitget 已上线 SKDD、GILD、TMF 等 9 只股票永续合约","url":"https://stock-news.laohu8.com/highlight/detail?id=2654027040","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654027040?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 11:11","pubTimestamp":1785208272,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方公告，为满足用户多元化投资需求，Bitget 已上线 SKDD（2 倍做空 SK 海力士 ETF）、SKUU（2 倍做多 SK 海力士 ETF）、GILD（Gilead Sciences）、TMF（3 倍做多美国长期国债 ETF）等 9 只股票及 ETF 永续合约。\n\n上述合约均以 USDT 结算，支持最高 20 倍杠杆和 7×24 小时交易。更多详情可参阅 Bitget 官方平台。\n\n\n ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2278557","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","BK4583","IE00BKVL7J92.USD","LU1430594728.SGD","LU0114720955.EUR","SG9999015978.USD","BK4566","IBBQ","LU0882574055.USD","IE00B19Z3581.USD","SG9999015945.SGD","LU0965509283.SGD","LU1066053197.SGD","SG9999015986.USD","LU0823416689.USD","MEDI","LU0965509010.AUD","GILD","LU0861579265.USD","LU0965509101.SGD","LU2324357040.USD","LU1934455863.HKD","LU0058720904.USD","LU0320765992.SGD","BK4588","LU1674673428.USD","TMED","BK4550","LU0965508806.USD","LU0109394709.USD","LU1934455277.USD","BMED","LU1934455194.USD","LU1061106388.HKD","BBH","LU1037948541.HKD","BK4532","IE00B19Z3B42.SGD","BK4139","IE0002270589.USD","LU0122379950.USD","LU2112291526.USD","IBB","LU1839511570.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4578","LU1674673691.USD","BIB","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653080634","title":"安进提交新数据，对美国食品药品监督管理局（FDA）关于撤回Tavneos的提议提出异议","url":"https://stock-news.laohu8.com/highlight/detail?id=2653080634","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653080634?lang=zh_cn&edition=fundamental","pubTime":"2026-07-24 21:44","pubTimestamp":1784900670,"startTime":"0","endTime":"0","summary":"安进提交新数据，对美国食品药品监督管理局关于撤回Tavneos的提议提出异议路透7月24日-安进公司周五表示，该公司已于7月23日向美国食品药品监督管理局提交了新证据，以寻求举行听证会，对该公司的罕见病药物Tavneos拟从美国市场撤回的决定提出异议。美国食品药品监督管理局未立即回应路透的置评请求。美国食品药品监督管理局今年4月表示，除非安进公司主动撤回该药，或FDA局长下令撤回，否则Tavneos将继续在美国市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4T43Q16X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1057294990.SGD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","PJP","BK4581","IBBQ","LU2089984988.USD","BBH","LU0868494617.USD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4585","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765992.SGD","LU2242646821.SGD","IE0002141913.USD","LU1061106388.HKD","BIB","TBXU","BK4588","LU0109394709.USD","IBB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4533","LU1983299246.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4139","BK4534","PBE","AMGN","BK4599","LU2242652126.USD","BK4566","LU0122379950.USD","LU0058720904.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653895100","title":"吉利德科学(GILD)肿瘤组合疗法获欧洲药品管理局旗下CHMP推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653895100?lang=zh_cn&edition=fundamental","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","TBXU","BK4588","TMED","LU0122379950.USD","LU1066051498.USD","IE0002270589.USD","SG9999015986.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","SG9999015945.SGD","LU1057294990.SGD","IE00B3T34201.USD","BK4550","LU2324357040.USD","BK4583","IBBQ","CHMP","IE00B19Z3581.USD","LU2468319806.SGD","BBH","IBB","LU1934455194.USD","LU0965508806.USD","LU1061106388.HKD","LU2089984988.USD","LU1037948541.HKD","LU0289739699.SGD","LU0234570918.USD","LU0320765992.SGD","LU1571399168.USD","BK4139","LU1585245621.USD","BK4585","MEDI","LU0965509010.AUD","BK4578","LU1023059063.AUD","LU1934455863.HKD","BMED","SG9999015952.SGD","SG9999015978.USD","BIB","GILD","IE00BSNM7G36.USD","LU0058720904.USD","LU0889565916.HKD","LU2087621335.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推荐吉利德Trodelvy®联合Keytruda®用于PD-(L)1阳性一线转移性三阴性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_cn&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","IBB","SG9999015952.SGD","BK4568","TBXU","IE00B3T34201.USD","LU1778281490.HKD","BK4139","LU0823416689.USD","BMED","IBBQ","BK4532","LU1061106388.HKD","LU1839511570.USD","LU1037948541.HKD","LU0889565916.HKD","SG9999015978.USD","SG9999015986.USD","LU2087621335.USD","LU0122379950.USD","LU0320765992.SGD","LU1066053197.SGD","BK4550","BK4578","LU2089984988.USD","TMED","LU0965509010.AUD","LU0109394709.USD","IE00B19Z3581.USD","LU0882574055.USD","LU1066051498.USD","BK4585","LU1585245621.USD","IE00B7SZLL34.SGD","LU1934455194.USD","GILD","BK4583","IE00BSNM7G36.USD","LU0965508806.USD","LU1571399168.USD","BK4566","LU0058720904.USD","LU2112291526.USD","LU1430594728.SGD","LU1037948897.HKD","IE00BKVL7J92.USD","LU0861579265.USD","LU1023059063.AUD","LU0289739699.SGD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU2468319806.SGD","LU0234570918.USD","LU0965509283.SGD","SG9999015945.SGD","LU1934455277.USD","LU2324357040.USD","IE0002270589.USD","LU1674673691.USD","LU1934455863.HKD","LU1674673428.USD","BIB","BBH","LU0965509101.SGD","LU1057294990.SGD","MEDI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百济神州/安进 FIC 双抗，皮下制剂进入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688235","BK1583","KURE","III","PJP","LU1571399168.USD","LU0868494617.USD","LU2112291526.USD","BIB","IBB","BK1500","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4534","LU0122379950.USD","LU1770034418.SGD","LU0289739699.SGD","BK4134","LU1251922891.USD","LU1969619763.USD","BK4588","LU0307460666.USD","IE0002141913.USD","IBBQ","LU1983299246.USD","BK4139","06160","SG9999001440.SGD","LU2242652126.USD","TBXU","BK4585","LU2242646821.SGD","AMGN","LU0058720904.USD","PBE","LU1061106388.HKD","LU2468319806.SGD","BK4599","IE00B4R5TH58.HKD","BK4581","LU1303224171.USD","LU0588546209.SGD","LU1719994722.HKD","BK1588","LU0320765992.SGD","IE0009355771.USD","BBH","ONC","LU2328871848.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749341","title":"argenx(ARGX)二季度产品净销售额达15.16亿美元 同比增长60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749341","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653749341?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 18:18","pubTimestamp":1784801894,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球自身免疫疾病龙头生物科技公司 argenx 发布了2026年第二季度及上半年财报。其中，2026年第二季度，公司实现产品净销售额 15.16亿美元，同比大幅增长 60%，环比增长 17%。资金储备方面，截至2026年6月30日，argenx 拥有的现金、现金等价物及流动金融资产达 52亿美元，显著高于2025年底的44亿美元，为后续临床研发及商业化扩张提供了雄厚的资金屏障。截至2026年底，argenx 预计将有10款药物分子处于临床研发阶段。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","FMED","IE00BJT1NW94.SGD","LU0889565916.HKD","IBB","IE00B2B36J28.USD","BK4139","BK4585","LU2324357040.USD","IE0009355771.USD","IE0034235188.USD","BK4505","IE0002141913.USD","LU1983260115.SGD","TBXU","IE00BJJMRZ35.SGD","ARGX","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712957","title":"美国研究综述-Alphabet、IBM、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712957","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653712957?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 15:30","pubTimestamp":1784791811,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、IBM、特斯拉路透7月23日-周四，华尔街证券分析师调整了包括Alphabet、IBM和特斯拉在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4T43P0KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEV","SF","RJF","CELH","GOOW","CME","SKYY","SNDK","ARWR","GOOX","KNX","ROL","XOM","MCB","IPAR","MPC","BMI","CCI","CVNA","FTNT","BLFS","CDNA","EWBC","PSX","NOC","EOG","FTAI","ARTY","EFX","IBM","BP","CLIX","AMDS","GILD","NTRS","DIG","WUGI","SEIC","EFIV","CVX","AMD","T","GOOGL","PEGA","MNPR","IBB","GSHD","BAI","CASH","KDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_cn&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","LU0130102774.USD","LU0957799991.USD","LU1929549753.HKD","LU2357627491.SGD","LU2361044865.SGD","LU0920840948.USD","LU1496350502.SGD","LU0265550359.USD","LU1093756168.USD","LU2023251221.USD","IE00B2B36J28.USD","LU0949170426.SGD","GILD","BMED","LU0114720955.EUR","LU1019632923.USD","LU1003077747.HKD","LU0077335932.USD","LU1015430645.USD","LU1116320901.HKD","688317","IE000M9KFDE8.USD","MRNX","LU0997586432.USD","LU0345777147.USD","BK4588","BK4532","LU2023250504.SGD","SG9999015952.SGD","LU0006306889.USD","LU1037948541.HKD","GDOC","LU1267930813.SGD","LU1078025761.USD","SG9999014567.USD","LU0868494617.USD","LU1153584641.USD","SGXZ57979304.SGD","LU0575583348.USD","LU1585245621.USD","BK0239","LU0942090050.USD","LU0320765489.SGD","LU0823434583.USD","LU0052756011.USD","LU1057294990.SGD","LU0985320562.USD","LU0949170772.SGD","LU2133065610.SGD","BK4516","LU0792757196.USD","LU2433249047.HKD","LU1829250122.USD","SG9999014575.USD","BBH","FTXH","LU1839511570.USD","LU2125909593.SGD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU0106261372.USD","BIB","LU1035773651.USD","IE00B1BXHZ80.USD","LU0640478417.SGD","IDNA","LU0011850046.USD","LU0130517989.USD","LU1863844749.USD","LU1496350171.SGD","IE00B4R5TH58.HKD","BK4550","LU0859254822.USD","LU1880407215.USD","SG9999015341.SGD","LU2237443465.HKD","SG9999014542.SGD","LU0158827948.USD","LU0234570918.USD","LU0211331839.USD","IE0009355771.USD","LU1301847155.USD","IE00B19Z3581.USD","LU3187612489.SGD","PPH","SG9999001176.SGD","LU2023250843.SGD","BK4534","IHE","SG9999015945.SGD","LU2237438978.USD","LU0203345920.USD","LU1323610961.USD","LU0098860793.USD","IBBQ","LU1066051225.USD","LU0823399737.USD","LU0345777659.USD","SG9999013999.USD","LU1061106388.HKD","LU0289739699.SGD","LU2087621335.USD","IYH","OSUR","IE00BBT3K403.USD","LU0029864427.USD","LU1196032939.SGD","IE00BLSP4239.USD","LU1430594728.SGD","BK4548","LU0320765992.SGD","TMED","LU0211327993.USD","LU0070302665.USD","LU0058720904.USD","LU0208291251.USD","LU0553294199.USD","LU1066053197.SGD","LU1355424745.HKD","LU0171276677.USD","LU0784385840.USD","LU0320765646.SGD","LU1064927863.SGD","AZN.UK","LU0499090636.EUR","LU1941712264.USD","PAWZ","LU1267930573.SGD","LU1037948897.HKD","LU0310799852.SGD","LU0557290698.USD","REGN","LU0887340254.USD","IE00BLSP4452.SGD","LU2112291526.USD","LU2293690082.USD","BK4578","LU0689626769.HKD","LU1941712348.USD","TRUH","LU1201861249.SGD","LU1153585028.USD","BK4198","LU0122379950.USD","LU2114397693.USD","LU1170363599.USD","LU0965509283.SGD","LU1162221912.USD","LU0171293334.USD","BK4007","IE0034235188.USD","LU1093756325.SGD","LU0648001328.SGD","LU1974910355.USD","LU1674673428.USD","LU1778281490.HKD","LU2237443622.USD","LU1023059063.AUD","LU0432979614.USD","LU2360032135.SGD","LU0868494708.USD","LU1934455863.HKD","LU2237443978.SGD","IE00BZ1G4Q59.USD","LU2362541273.HKD","LU0265550946.USD","LU1487256676.USD","LU2091194634.USD","SG9999001440.SGD","LU0047473722.EUR","LU0757432116.USD","LU0823416689.USD","LU1051770623.HKD","IE00B19Z3B42.SGD","XLV","LU0827474353.SGD","LU0823434740.USD","LU2539964713.USD","IE00BSNM7G36.USD","BK4559","03165","BK4585","LU1880407132.USD","LU1267930227.SGD","LU1917777945.USD","LU1481599808.USD","LU0526926950.USD","GNOM","LU0109394709.USD","LU1863844665.USD","SG9999002232.USD","LU1084165304.USD","IXJ","LU2324357040.USD","LU1699723380.USD","BK4501","LU1923622614.USD","HRTS","LU1261432733.SGD","LU1116320737.USD","LU0477156953.USD","LU0969580561.USD","LU1989772923.USD","LU0211326839.USD","SG9999002224.SGD","JDOC","LU1571399168.USD","BK4583","LU0960981461.USD","IE00BJJMRZ35.SGD","LU0211328371.USD","BK4551","LU0889565080.SGD","LU1066051498.USD","LU0965508806.USD","LU1934455194.USD","LU1069347547.HKD","RXL","LU1983299246.USD","LU0997586515.USD","LU0965509010.AUD","LU2362540622.SGD","LU2237443895.HKD","LU1046234339.USD","SG9999015358.SGD","LU0972486137.USD","LU0234572021.USD","LU2361045086.USD","SG9999015978.USD","LU0965509101.SGD","LU2361044949.HKD","BK5011","IBB","LU0211326755.USD","LU0882574055.USD","SG9999015986.USD","LU0053666078.USD","LU0861579265.USD","IE00B7SZLL34.SGD","LU0310800965.SGD","LGHT","FHLC","LU2089283258.USD","LU0920783379.SGD","LU2491050154.USD","VHT","LU0545039389.USD","LU2237443382.USD","LU0203347892.USD","SG9999001176.USD","IE00BKVL7J92.USD","LU0784383803.USD","LU2125909247.SGD","LU0889566641.SGD","IE00B3T34201.USD","LU0889565916.HKD","BK4139","LU0784385170.HKD","LU2089984988.USD","LU2089284900.SGD","LU0980610538.SGD","LU0124676726.USD","LU2237443549.SGD","BK4568","IE00BKPKM643.USD","LU2125154778.USD","MRK","LU0784384876.USD","MEDI","IE0002141913.USD","LU0496365809.HKD","LU1019634622.SGD","IE00BFTCPJ56.SGD","LU1273509221.SGD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU1267930490.SGD","LU2125154935.USD","LU1119994496.HKD","LU2491050071.SGD","LU1934455277.USD","LU0310800379.SGD","LU0128525929.USD","LU0128525689.USD","SG9999014559.SGD","LU1291159041.SGD","LU2491049909.HKD","BK4566","LU0708994859.HKD","LU0963555726.SGD","LU0047473722.SGD","LU2106854487.HKD","LU2108987350.USD","LU2468319806.SGD","LU0661504455.SGD","LU2279689827.SGD","BK4533","LU2362541513.USD","LU0964806797.USD","LU0390134368.USD","LU1989771016.USD","LU2293690249.USD","IE0002270589.USD","LU1003076772.USD","LU1674673691.USD","LU1814569148.SGD","TBXU","LU0266013472.USD","LU0857590862.USD","LU1104425308.USD","LU0238689110.USD","LU1481600234.SGD","LU0738911758.USD","WDNA","LU2355687059.USD","LU1989772840.SGD","MRNY","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"创新药研发加速遇“猴荒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_cn&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BIOY","XLVI","APXH","WRND","BBP","GDOC","BK4585","BK4588","PBE","IBB","LFSC","GSKH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_cn&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","LU1778281490.HKD","LU0058720904.USD","BBH","BMED","LU0432979614.USD","LU0861579265.USD","LU1066053197.SGD","LU1023059063.AUD","LU2087621335.USD","JDOC","GILD","PAWZ","LU1941712348.USD","BIB","IBBQ","LU1093756168.USD","LU1929549753.HKD","LU1291159041.SGD","TBXU","SG9999014542.SGD","TRUH","MEDI","TMED","LU0868494708.USD","XLV","IXJ","IE00BJJMRZ35.SGD","GDOC","RXL","LU2089984988.USD","SG9999001176.USD","IE00B2B36J28.USD","IYH","IBB","LU1989771016.USD","LU1699723380.USD","LU1923622614.USD","LU0266013472.USD","LU1983299246.USD","IHE","LU2324357040.USD","LU2023250843.SGD","FTXH","FHLC","LU0889565916.HKD","PPH","VHT","HRTS","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","IE00BJT1NW94.SGD","TBXU","BK4585","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B4R5TH58.HKD","PJP","LU2112291526.USD","LU0289739699.SGD","BK4139","LU1057294990.SGD","LU0320765992.SGD","BK4566","IE00BJJMRZ35.SGD","LU2242652126.USD","BK4588","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","SG9999001440.SGD","BBH","BK4533","LU0058720904.USD","BK4581","IBB","AMGN","IBBQ","BIB","IE0002141913.USD","LU1023059063.AUD","PBE","IE0009355771.USD","BK4534","LU2468319806.SGD","LU1061106388.HKD","LU2242646821.SGD","LU2089984988.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下调吉利德科学评级至“与大盘持平”，目标价大幅调降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU0861579265.USD","SG9999015945.SGD","LU1839511570.USD","GILD","LU1934455194.USD","IE00BSNM7G36.USD","LU0882574055.USD","LU1061106388.HKD","LU1674673691.USD","BBH","BIB","LU0823416689.USD","BK4532","LU0114720955.EUR","SG9999015952.SGD","IBBQ","LU0889565916.HKD","LU1023059063.AUD","LU1934455277.USD","IE00B3T34201.USD","LU0058720904.USD","BK4139","LU1674673428.USD","BK4583","LU1057294990.SGD","BK4566","BK4578","LU0109394709.USD","LU0965508806.USD","LU0965509101.SGD","IBB","LU1066051498.USD","SG9999015986.USD","BMED","IE00BKVL7J92.USD","LU1585245621.USD","LU1571399168.USD","LU2112291526.USD","LU2468319806.SGD","BK4588","LU1934455863.HKD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4568","MEDI","IE00B19Z3581.USD","LU1430594728.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1778281490.HKD","LU2089984988.USD","LU0122379950.USD","TBXU","TMED","IE00B7SZLL34.SGD","LU1037948897.HKD","LU0965509010.AUD","BK4585","LU2324357040.USD","LU2087621335.USD","BK4550","LU1037948541.HKD","LU1066053197.SGD","LU0234570918.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下调吉利德科学目标价至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","BK4578","LU0965509101.SGD","LU2468319806.SGD","IBB","SG9999015945.SGD","LU0234570918.USD","IBBQ","LU0289739699.SGD","IE00BKVL7J92.USD","LU0320765992.SGD","LU0965509283.SGD","LU1778281490.HKD","IE00BSNM7G36.USD","LU1839511570.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1585245621.USD","BK4583","BK4585","SG9999015986.USD","IE00B7SZLL34.SGD","LU1674673428.USD","LU2089984988.USD","BK4550","LU1934455863.HKD","LU0122379950.USD","LU2324357040.USD","BMED","LU1066053197.SGD","UDN","SG9999015978.USD","LU0965509010.AUD","LU1674673691.USD","BBH","LU0114720955.EUR","LU2087621335.USD","LU0058720904.USD","LU0109394709.USD","LU0882574055.USD","MEDI","LU1023059063.AUD","LU0889565916.HKD","UUP","LU0861579265.USD","LU1037948541.HKD","GILD","BIB","IE00BZ1G4Q59.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi将允许对临床试验和FDA决定进行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_cn&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4578","BK4588","LU1057294990.SGD","LU2468319806.SGD","IBB","SG9999015945.SGD","LU0234570918.USD","IBBQ","LU1934455277.USD","LU0965509283.SGD","IE00BSNM7G36.USD","BK4566","LU1839511570.USD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1061106388.HKD","LU1585245621.USD","LU1037948897.HKD","IE00B19Z3581.USD","BK4585","IE00B7SZLL34.SGD","LU1674673428.USD","LU2089984988.USD","LU1934455863.HKD","LU0122379950.USD","LU2324357040.USD","BMED","SG9999015978.USD","LU1066051498.USD","LU1674673691.USD","IE0002270589.USD","LU0965508806.USD","BBH","LU0114720955.EUR","LU2087621335.USD","LU0058720904.USD","LU0109394709.USD","LU0882574055.USD","MEDI","LU0889565916.HKD","LU0861579265.USD","SMMT","LU1037948541.HKD","GILD","BIB","BK4583","LU2112291526.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495621","title":"三星生物制剂与欧加农将在澳大利亚推出新型生物类似药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651495621?lang=zh_cn&edition=fundamental","pubTime":"2026-07-16 04:04","pubTimestamp":1784145897,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IBB","LU2322448791.USD","LU2272731782.SGD","EMXC","IE00B5TLWC47.USD","LU2473716301.USD","LU1992135399.USD","XPH","PPH","LU1992135472.HKD","LU2272731865.HKD","LU2322448957.HKD","LU2272731600.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_cn&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BBH","LU2324357040.USD","LU1037948897.HKD","LU1061106388.HKD","LU0965509010.AUD","LU0965508806.USD","LU1934455194.USD","BK4588","IBB","IE00BSNM7G36.USD","BK4583","BK4550","LU0823416689.USD","LU1430594728.SGD","LU1571399168.USD","SG9999015986.USD","BK4578","LU1057294990.SGD","IE0002270589.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1066053197.SGD","LU1674673691.USD","IE00BKVL7J92.USD","LU0861579265.USD","LU0965509283.SGD","LU2089984988.USD","IBBQ","LU1934455863.HKD","MEDI","SG9999015978.USD","IE00BZ1G4Q59.USD","BIB","LU0234570918.USD","LU2468319806.SGD","LU1023059063.AUD","BK4566","IE00B7SZLL34.SGD","LU1839511570.USD","BMED","LU1934455277.USD","LU2087621335.USD","LU0320765992.SGD","IE00B3T34201.USD","GILD","LU0114720955.EUR","LU0289739699.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百亿美元收购罕见病药企 拓宽内分泌管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_cn&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035775433.USD","IBB","BK4588","LU0432979614.USD","LU1069344957.HKD","SG9999001176.SGD","BK4585","LU1093756325.SGD","IE0009355771.USD","IE0002141913.USD","SG9999001176.USD","LU2362540622.SGD","LU2237438978.USD","LU2417539215.USD","IE00B2B36J28.USD","BK4532","BBH","LU1585245621.USD","SG9999013999.USD","IE00B894F039.SGD","LU0566484027.USD","CRNX","BIB","LU0889565916.HKD","VERX","IE00BZ9MQY76.HKD","IDNA","LU2362541273.HKD","IE00B19Z3581.USD","LU2456880835.USD","LU0757428866.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","LU2362541513.USD","LU2462157665.USD","PBE","BK4007","IE00B19Z9Z06.USD","IE0002270589.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU1674673428.USD","LU0061475181.USD","LU0256863811.USD","VRTX","LU0079474960.USD","IBBQ","IE00B4R5TH58.HKD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183275253","title":"Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1183275253","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183275253?lang=zh_cn&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946106,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Pliant Therapeutics今日宣布，任命Flavia Borellini博士与Robert Iannone博士为公司董事会新成员。这两项任命为董事会注入了深厚的全球肿瘤药物开发经验，并进一步强化了其在运营与监管事务方面的专业能力。目前，除了在Pliant任职外，他还担任Autolus Therapeutics的董事会成员。关于Pliant Therapeutics, Inc.：Pliant Therapeutics是一家临床阶段的生物制药公司，专注于基于整合素的疗法的发现与开发。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LENZ","BK4585","BK4139","BK4588","R","BK4539","IBB","BK4007","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711531","title":"RBC将Kymera Therapeutics的评级下调至“与行业持平”，并上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711531","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651711531?lang=zh_cn&edition=fundamental","pubTime":"2026-07-13 18:52","pubTimestamp":1783939974,"startTime":"0","endTime":"0","summary":"BUZZ-RBC将Kymera Therapeutics的评级下调至“与行业持平”，并上调目标价7月13日-** RBC资本市场将Kymera Therapeutics（KYMR.O）的评级从“跑赢大盘”下调至“与行业持平”，同时将其目标价从106美元上调至115美元** RBC表示，Kymera的KT-621是一种用于治疗中重度嗜酸性粒细胞性哮喘的每日一次实验性口服药，其在临床终点和生物标志物方","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4T43F0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0889565916.HKD","BK4588","LU2362541273.HKD","IBBQ","BBH","LU2023250504.SGD","LU1974910355.USD","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","LU0823434583.USD","LU0289739699.SGD","LU0823416689.USD","LU0114720955.EUR","LU0320765992.SGD","LU0053666078.USD","LU2237438978.USD","BK4585","LU2089984988.USD","BK4139","IBB","LU2362541513.USD","LU2468319806.SGD","LU2106854487.HKD","LU0823434740.USD","LU2362540622.SGD","LU1917777945.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}